We evaluate the neuropathology of Down Syndrome in collaboration with Dr. Elizabeth Head, as part of the Alzheimer’s Biomarkers Consortium – Down Syndrome. The goal includes identifying biomarkers of progression for Alzheimer’s Disease in Down Syndrome patients. The picture shows many plaques in the cerebral cortex that may be seen with Down syndrome.
